Document:

Exhibit 10.66

 

 

AETHLON MEDICAL, INC.

NOTICE OF GRANT OF STOCK OPTION

 

 

 

Notice is hereby given
of the following grant of an option to purchase shares of the Common Stock of Aethlon Medical, Inc., a Nevada corporation (the
“Company”):

 

 

	Optionee:  	Richard H. Tullis
	 	 
	 	 
	Grant Date:  	September 27, 2010
	 	 
	 	 
	Exercise Price:  	$0.25 per share
	 	 
	 	 
	Number of Option Shares:  	1,000,000
	 	 
	 	 
	Expiration Date:  	September 27, 2020
	 	 
	Type of Option:	Nonqualified Stock Option
	 	 
	 	 
	Vesting Schedule	500,000 shall vest immediately and 500,000 shall vest on September 27, 2011

 

 

Optionee agrees to be bound
by the terms of the Stock Option Agreement attached hereto as Exhibit A.

 

No Employment or Service
Contract. Nothing in this Notice or in the attached Stock Option Agreement shall confer upon Optionee any right to continue
in service in any capacity, including as an employee, for any period of specific duration or interfere with or otherwise restrict
in any way the rights of the Company (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights
are hereby expressly reserved by each, to terminate Optionee’s service and/or employment at any time for any reason, with
or without cause.

 

 

    	 	 	 

     

    

 

Definitions. All
capitalized terms in this Notice shall have the meaning assigned to them in this Notice or the Company’s 2010 Stock Incentive
Plan.

 

	Dated as of:  September 27, 2010	Aethlon Medical, Inc.
	 	 
	 	 
	 	 
	 	By:  /s/ James A. Joyced
	 	Name:       James A. Joyce
	 	                  Chairman and Chief Executive Officer
	 	 
	 	OPTIONEE
	 	 
	 	 
	 	/s/ Richard H. Tullis
	 	Name:             Richard H. Tullis
	 	Address:       1320 Saxony Road
	 	                        Encinitas, CA 92024

 

ATTACHMENTS

Exhibit A - Stock Option Agreement

 

    	 	 	 

     

    

 

EXHIBIT A

AETHLON MEDICAL, INC.

STOCK OPTION AGREEMENT

 

RECITALS

 

The Board of Directors
of Aethlon Medical, Inc. (the “Company”), in a telephonic Board Meeting held September 27, 2010, has deemed it fair
and in the best interest of the Company and its stockholders that the Company issue to Richard H. Tullis (the “Optionee”)
an option to acquire an aggregate of 1,000,000 shares of restricted Common Stock of the Company.

 

All capitalized terms in
this Agreement not defined herein shall have the meaning assigned to them in the attached Appendix or in the Company’s 2010
Stock Incentive Plan (the “Plan”).

 

AGREEMENT

 

NOW, THEREFORE, it
is hereby agreed as follows:

 

1.                 
Grant of Option. The Company hereby grants to the Optionee, as of the Grant Date, an option to purchase up to
the number of Option Shares specified in the Grant Notice. The Option Shares shall be purchasable from time to time during the
option term specified in Paragraph 2 at the Exercise Price. Except as otherwise provided herein, this option shall be subject to
the terms and conditions of the Plan.

 

2.                 
Option Term. This option shall expire at the close of business on the Expiration Date, unless sooner terminated
in accordance with Paragraph 5.

 

3.                 
Limited Transferability.  During Optionee’s lifetime, this option shall be exercisable only by Optionee
and shall not be assignable or transferable other than by will or by the laws of descent and distribution following Optionee’s
death.

 

4.                 
Dates of Exercise. This option shall become exercisable for the Option Shares as specified in the Vesting Schedule.

 

5.                 
Cessation of Service. The exercise of this option shall be subject to the provisions of Section 6.6 of the Plan
with respect to exercise after Termination of the Optionee; provided that, for the avoidance of doubt, no previously unexercisable
portion of this option shall become exercisable after such Termination.

 

6.                 
Stockholder Rights.  The holder of this option shall not have any rights as a stockholder of the Company with
respect to the Option Shares until such person shall have exercised the option, paid the Exercise Price and become a holder of
record of the purchased shares.

 

 

    	 	1	 

     

    

 

7.                 
Manner of Exercising Option.

 

(a)In order to exercise
this option with respect to all or any part of the Option Shares for which this option is at the time exercisable, the Optionee
(or any other person or persons exercising the option) must take the following actions:

 

(i)Execute
and deliver to the Company a written notice setting forth the number of Option Shares for which the option is exercised;

 

(ii)Pay the
aggregate Exercise Price for the purchased shares in cash or in one or more of the following forms:

 

(A)by
cancellation of indebtedness of the Company to the Optionee;

 

(B)if approved
by the Board, by surrender of shares that either: (1) have been owned by the Optionee for more than one year and have been paid
for within the meaning of Rule 144 promulgated under the Securities Act (and, if such shares were purchased from the Company by
use of a promissory note, such note has been fully paid with respect to such shares); or (2) were obtained by the Optionee in the
public market;

 

(C)if
approved by the Board, by waiver of compensation due or accrued to the Optionee for services rendered;

 

(D)with respect
only to purchases upon exercise of an option, and provided that a public market for the Company’s stock exists:

 

(1)through a “same
day sale” commitment from the Optionee and a broker-dealer that is a member of the Financial Industry Regulatory Authority
(a “FINRA Dealer”) whereby the Optionee irrevocably elects to exercise the option and to sell a portion of the shares
so purchased to pay for the Exercise Price, and whereby the FINRA Dealer irrevocably commits upon receipt of such shares to forward
the Exercise Price directly to the Company; or

 

(2)through a “margin”
commitment from the Optionee and an FINRA Dealer whereby the Optionee irrevocably elects to exercise the option and to pledge the
Shares so purchased to the FINRA Dealer in a margin account as security for a loan from the FINRA Dealer in the amount of the Exercise
Price, and whereby the FINRA Dealer irrevocably commits upon receipt of such Shares to forward the Exercise Price directly to the
Company; or

 

(E)by any
combination of the foregoing. Except to the extent the sale and remittance procedure is utilized in connection with the option
exercise, payment of the Exercise Price must accompany the written notice delivered to the Company in connection with the option
exercise;

 

 

    	 	2	 

     

    

 

(iii)Furnish
to the Company appropriate documentation that the person or persons exercising the option (if other than Optionee) have the right
to exercise this option;

 

(iv)Execute
and deliver to the Company such written representations as may be requested by the Company in order for it to comply with the applicable
requirements of federal and state securities laws; and

 

(v)Make appropriate
arrangements with the Company for the satisfaction of all federal, state and local income and employment tax withholding requirements
applicable to the option exercise.

 

(b)As soon as practical
after the Exercise Date, the Company shall issue to or on behalf of the Optionee (or any other person or persons exercising this
option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto.

 

(c)In no event may this
option be exercised for any fractional shares.

 

8.                 
Compliance with Laws and Regulations.

 

(a)The exercise of this
option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Company and the Optionee
with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange (or the OTC
Bulletin Board, if applicable) on which the Common Stock may be listed for trading (or quoted) at the time of such exercise and
issuance.

 

(b)The inability of the
Company to obtain approval from any regulatory body having authority deemed by the Company to be necessary to the lawful issuance
and sale of any Common Stock pursuant to this option shall relieve the Company of any liability with respect to the non-issuance
or sale of the Common Stock as to which such approval shall not have been obtained. The Company, however, shall use its best efforts
to obtain all such approvals.

 

9.                 
Successors and Assigns. Except to the extent otherwise provided in Paragraph 3, the provisions of this Agreement
shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and the Optionee, the Optionee’s
assigns and the legal representatives, heirs and legatees of the Optionee’s estate.

 

10.             
Notices. Any notice required to be given or delivered to the Company under the terms of this Agreement shall
be in writing and addressed to the Company at its principal corporate offices. Any notice required to be given or delivered to
the Optionee shall be in writing and addressed to the Optionee at the address indicated below the Optionee’s signature line
on the Grant Notice. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid
and properly addressed to the party to be notified.

 

 

    	 	3	 

     

    

 

11.             
Governing Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws
of the State of California without resort to the conflict-of-laws rules thereof.

 

 

 

 

 

 

 

 

 

 

    	 	4	 

     

    

 

 

IN WITNESS WHEREOF,
the undersigned have duly executed this Agreement as of September 27, 2010.

 

	 	Aethlon Medical, Inc., a Nevada corporation	 
	 	 	 	 
	 	By: 	 /s/ James B. Frakes	 
	 	 	James B. Frakes	 
	 	 	Chief Financial Officer	 

 

	 	Optionee	 
	 	 	 	 
	 	By: 	 /s/ Richard H. Tullis	 
	 	 	Richard H. Tullis	 

  

 

    	 	5	 

     

    

 

APPENDIX A

 

The following definitions shall be
in effect under the Agreement:

 

		1.	Agreement shall mean this Stock Option Agreement.

 

		2.	Common Stock shall mean the Company’s common stock.

 

		3.	Exercise Date shall mean the date on which the option shall have been exercised in
accordance with Paragraph 7 of the Agreement.

 

		4.	Exercise Price shall mean the exercise price payable per Option Share as specified
in the Grant Notice.

 

		5.	Expiration Date shall mean the date on which the option expires as specified in
the Grant Notice.

 

		6.	Grant Date shall mean the date of grant of the option as specified in the Grant Notice.

 

		7.	Grant Notice shall mean the Notice of Grant of Stock Option accompanying the Agreement,
pursuant to which Optionee has been informed of the basic terms of the option evidenced hereby.

 

		8.	Option Shares shall mean the number of shares of Common Stock subject to the option.

 

		9.	Vesting Schedule shall mean the vesting schedule specified in the Grant Notice pursuant
to which the Option Shares shall become exercisable.

 

 

 

 

 

    	 	6Exhibit 10.67

 

 

AETHLON MEDICAL, INC.

AMENDMENT NO. 1 TO

STOCK OPTION AGREEMENT

 

RECITALS

 

The Board of Directors (the “Board”)
of Aethlon Medical, Inc. (the “Company”), in a written consent in lieu of a Board Meeting dated February 9, 2016, has
deemed it fair and in the best interest of the Company and its stockholders that Section 5 of the Stock Option Agreement between
the Company and Richard H. Tullis dated July 1, 2013 be amended (the “Amendment”) as set forth below. Accordingly,
the undersigned agree that such section is amended hereby to read in its entirety as follows:

 

 

5.           Cessation
of Service. The option term specified in Paragraph 2 shall terminate (and this option shall cease to be outstanding) prior
to the Expiration Date should any of the following events occur:

 

(a)           If
the Optionee’s service is terminated for any reason other than death or disability, then the Optionee may exercise this option,
only to the extent that the option would have been exercisable upon the date of such termination (the “Termination Date”),
no later than thirty-six (36) months after the Termination Date, or the Expiration Date, whichever occurs first.

 

(b)           If
the Optionee’s service is terminated because of the Optionee’s death or disability (or the Optionee dies within thirty-six
(36) months after a termination other than for cause or because of the Optionee’s disability), then this option may be exercised
only to the extent that it would have been exercisable by the Optionee on the Termination Date and must be exercised by the Optionee
(or the Optionee’s legal representative) no later than thirty-six (36) months after the Termination Date, or the Expiration
Date, whichever occurs first.

 

(c)           Notwithstanding
the provisions above, if the Optionee’s service is terminated for cause, neither the Optionee, the Optionee’s estate
nor such other person who may then hold this option shall be entitled to exercise it with respect to any Option Shares whatsoever.

 

 

 

IN WITNESS WHEREOF, the parties have executed
this Amendment on this 9th day of February, 2016.

 

 

	 	Aethlon Medical, Inc., a Nevada corporation	 
	 	 	 	 
	 	By: 	 /s/ James B. Frakes	 
	 	 	James B. Frakes	 
	 	 	Chief Financial Officer	 

 

	 	Optionee	 
	 	 	 	 
	 	By: 	 /s/ Richard H. Tullis	 
	 	 	Richard H. Tullis

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]